Gambaran Umum
Cybin Inc., based in Canada, operates within the biotechnology industry, primarily focusing on the development of psychedelic compounds to potentially treat mental health issues. The company is noteworthy for its pioneering research on psilocybin-based therapies, exploring their use in addressing depression and anxiety disorders. Cybin Inc. is involved in extensive clinical trials to verify the safety and efficacy of these psychedelic treatments. Aside from its original projects in psychedelics, Cybin also emphasizes innovation in delivery mechanisms to enhance patient outcomes. This includes the development of novel drug delivery systems that aim to improve the administration and effectiveness of their therapeutic compounds, positioning Cybin at the forefront of the psychedelics-based therapeutic industry.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Cybin Inc. per 2025 Jun 30 adalah -114.73 MM.
- Nilai net income untuk Cybin Inc. per 2025 Jun 30 adalah -96.73 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | -114.73 | -96.73 | |
| 2025-03-31 | -143.15 | -113.14 | |
| 2024-12-31 | -135.10 | -103.90 | |
| 2024-09-30 | -130.79 | -123.69 | |
| 2024-06-30 | -63.17 | -57.28 | |
| 2024-03-31 | -78.84 | -78.08 | |
| 2023-12-31 | -67.34 | -70.45 | |
| 2023-09-30 | -52.41 | -50.87 | |
| 2023-06-30 | -50.83 | -48.95 | |
| 2023-03-31 | -51.52 | -47.49 | |
| 2022-12-31 | -54.15 | -51.87 | |
| 2022-09-30 | -58.52 | -58.34 | |
| 2022-06-30 | -63.29 | -65.97 | |
| 2022-03-31 | -63.84 | -67.63 | |
| 2021-12-31 | 0.00 | -60.38 | -63.31 |
| 2021-09-30 | 0.00 | -55.30 | -57.52 |
| 2021-06-30 | 0.00 | -40.75 | -42.57 |
| 2021-03-31 | 0.86 | -31.04 | -32.22 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | -5.65 | -5.69 |
| 2024-09-30 | -8.03 | -8.08 |
| 2024-06-30 | -6.56 | -6.66 |
| 2024-03-31 | ||
| 2023-12-31 | -11.36 | -11.48 |
| 2023-09-30 | -9.36 | -9.49 |
| 2023-06-30 | -9.64 | -9.91 |
| 2023-03-31 | -9.73 | -9.88 |
| 2022-12-31 | -10.96 | -10.80 |
| 2022-09-30 | -12.62 | -12.47 |
| 2022-06-30 | -14.59 | -14.38 |
| 2022-03-31 | -15.36 | -15.20 |
| 2021-12-31 | -14.41 | -14.36 |
| 2021-09-30 | -14.94 | -14.88 |
| 2021-06-30 | -13.02 | -12.79 |
| 2021-03-31 | -12.24 | -12.16 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Cybin Inc. per 2025 Jun 30 adalah -83.93 MM.
- Nilai cash from investing activities untuk Cybin Inc. per 2025 Jun 30 adalah -1.49 MM.
- Nilai kas dari aktivitas pendanaan untuk Cybin Inc. per 2025 Jun 30 adalah 69.61 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -83.93 | -1.49 | 69.61 |
| 2025-03-31 | -101.30 | -1.97 | 20.20 |
| 2024-12-31 | -100.89 | -1.10 | 190.08 |
| 2024-09-30 | -99.81 | 6.67 | 230.00 |
| 2024-06-30 | -62.42 | 4.93 | 183.21 |
| 2024-03-31 | -68.91 | 6.92 | 254.51 |
| 2023-12-31 | -59.04 | 6.92 | 68.79 |
| 2023-09-30 | -43.77 | -0.75 | 32.51 |
| 2023-06-30 | -46.99 | -3.17 | 16.77 |
| 2023-03-31 | -47.43 | -3.31 | 13.56 |
| 2022-12-31 | -46.31 | -3.21 | 8.49 |
| 2022-09-30 | -48.36 | -3.17 | 6.43 |
| 2022-06-30 | -47.47 | -0.58 | 35.76 |
| 2022-03-31 | -45.21 | -0.77 | 35.78 |
| 2021-12-31 | -42.05 | -2.09 | 67.75 |
| 2021-09-30 | -37.73 | -1.00 | 110.07 |
| 2021-06-30 | -26.30 | -1.58 | 75.30 |
| 2021-03-31 | -19.03 | -1.19 | 82.72 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 |
Efektivitas Manajemen
- roa untuk Cybin Inc. pada 2025 Jun 30 adalah -0.37.
- roe untuk Cybin Inc. pada 2025 Jun 30 adalah -0.35.
- roic untuk Cybin Inc. pada 2025 Jun 30 adalah -0.43.
- croic untuk Cybin Inc. pada 2025 Jun 30 adalah 0.40.
- ocroic untuk Cybin Inc. pada 2025 Jun 30 adalah -0.42.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -0.37 | -0.35 | -0.43 | 0.40 | -0.42 |
| 2025-03-31 | -0.80 | -0.39 | -0.43 | 0.40 | -0.42 |
| 2024-12-31 | -0.95 | -0.86 | -0.48 | 0.53 | -0.39 |
| 2024-09-30 | -1.36 | -2.56 | -0.28 | 0.62 | -0.31 |
| 2024-06-30 | -1.45 | -1.62 | -0.27 | 0.66 | -0.24 |
| 2024-03-31 | -1.16 | -1.25 | -0.58 | 0.14 | -0.49 |
| 2023-12-31 | -0.74 | -0.79 | -1.05 | -0.24 | -0.90 |
| 2023-09-30 | -0.66 | -0.72 | -1.23 | -0.83 | -1.18 |
| 2023-06-30 | -0.66 | -0.72 | -1.23 | -0.83 | -1.18 |
| 2023-03-31 | -0.56 | -0.62 | -0.98 | -0.77 | -0.98 |
| 2022-12-31 | -0.55 | -0.59 | -0.91 | -0.70 | -0.75 |
| 2022-09-30 | -0.55 | -0.59 | -0.91 | -0.70 | -0.75 |
| 2022-06-30 | -0.80 | -0.86 | -0.97 | -0.19 | -0.70 |
| 2022-03-31 | -0.73 | -0.79 | -0.89 | -0.14 | -0.59 |
| 2021-12-31 | -1.03 | -1.20 | -0.71 | 0.26 | -0.47 |
| 2021-09-30 | -9.94 | -12.32 | -0.58 | 0.72 | -0.38 |
| 2021-06-30 | -4.79 | -6.41 | -0.56 | 0.62 | -0.34 |
| 2021-03-31 | -18.84 | -22.25 | -0.37 | 0.72 | -0.22 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | -0.36 | -37.29 | -35.92 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1833141 |
Grupong Pang-industriya
| SIC 2834 - Pharmaceutical Preparations |
